On September 3, 2025, the US Food and Drug Administration (FDA) announced a new process to support the development of drugs intended to treat rare genetic diseases. The Rare Disease Evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback